Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP291007.RA9aA3_R0Q-haV2YJd-rfaW2rd_H7Gwey3a9abocAO-Gk130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP291007.RA9aA3_R0Q-haV2YJd-rfaW2rd_H7Gwey3a9abocAO-Gk130_assertion type Assertion NP291007.RA9aA3_R0Q-haV2YJd-rfaW2rd_H7Gwey3a9abocAO-Gk130_head.
- NP291007.RA9aA3_R0Q-haV2YJd-rfaW2rd_H7Gwey3a9abocAO-Gk130_assertion description "[Next, using the NK-92 (mCD16) we compared mouse mAbs directed at B lineage specific CD antigens for their ability to induce ADCC against human Epstein-Barr virus- infected B lymphoblastoid (for anti-CD19, -CD20 and -CD21) or against myeloma (for anti-CD38 and -CD138) target cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP291007.RA9aA3_R0Q-haV2YJd-rfaW2rd_H7Gwey3a9abocAO-Gk130_provenance.
- NP291007.RA9aA3_R0Q-haV2YJd-rfaW2rd_H7Gwey3a9abocAO-Gk130_assertion evidence source_evidence_literature NP291007.RA9aA3_R0Q-haV2YJd-rfaW2rd_H7Gwey3a9abocAO-Gk130_provenance.
- NP291007.RA9aA3_R0Q-haV2YJd-rfaW2rd_H7Gwey3a9abocAO-Gk130_assertion SIO_000772 23770975 NP291007.RA9aA3_R0Q-haV2YJd-rfaW2rd_H7Gwey3a9abocAO-Gk130_provenance.
- NP291007.RA9aA3_R0Q-haV2YJd-rfaW2rd_H7Gwey3a9abocAO-Gk130_assertion wasDerivedFrom befree-20150227 NP291007.RA9aA3_R0Q-haV2YJd-rfaW2rd_H7Gwey3a9abocAO-Gk130_provenance.
- NP291007.RA9aA3_R0Q-haV2YJd-rfaW2rd_H7Gwey3a9abocAO-Gk130_assertion wasGeneratedBy ECO_0000203 NP291007.RA9aA3_R0Q-haV2YJd-rfaW2rd_H7Gwey3a9abocAO-Gk130_provenance.